| Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications BJB Nelson, JD Andersson, F Wuest Pharmaceutics 13 (1), 49, 2020 | 146 | 2020 |
| Good practices for 68Ga radiopharmaceutical production BJB Nelson, JD Andersson, F Wuest, S Spreckelmeyer EJNMMI Radiopharmacy and Chemistry 7 (1), 27, 2022 | 55 | 2022 |
| Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers BJB Nelson, J Wilson, S Richter, MJM Duke, M Wuest, F Wuest Nuclear Medicine and Biology 80, 24-31, 2020 | 53 | 2020 |
| High yield cyclotron production of a novel 133/135La theranostic pair for nuclear medicine BJB Nelson, J Wilson, JD Andersson, F Wuest Scientific Reports 10 (1), 22203, 2020 | 28 | 2020 |
| First in vivo and phantom imaging of cyclotron-produced 133La as a theranostic radionuclide for 225Ac and 135La BJB Nelson, S Ferguson, M Wuest, J Wilson, MJM Duke, S Richter, ... Journal of Nuclear Medicine 63 (4), 584-590, 2022 | 27 | 2022 |
| Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy BJB Nelson, JD Andersson, F Wuest Nuclear Medicine and Biology 110, 59-66, 2022 | 18 | 2022 |
| Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications BJB Nelson, J Wilson, JD Andersson, F Wuest Pharmaceuticals 16 (11), 1622, 2023 | 15 | 2023 |
| High-yield cyclotron production of 203Pb using a sealed 205Tl solid target BJB Nelson, J Wilson, MK Schultz, JD Andersson, F Wuest Nuclear medicine and biology 116, 108314, 2023 | 15 | 2023 |
| EJNMMI Radiopharm BJB Nelson, JD Andersson, F Wuest, S Spreckelmeyer Chem 7, 1-26, 2022 | 8 | 2022 |
| A Theranostic Approach to Imaging and Treating Melanoma with 203Pb/212Pb-Labeled Antibody Targeting Melanin R Jiao, KJH Allen, ME Malo, O Yilmaz, J Wilson, BJB Nelson, F Wuest, ... Cancers 15 (15), 3856, 2023 | 6 | 2023 |
| Good practices for 68Ga radiopharmaceutical production. EJNMMI Radiopharm Chem. 2022; 7: 27 BJB Nelson, JD Andersson, F Wuest, S Spreckelmeyer | 6 | |
| 64Cu production via the 68Zn (p, nα) 64Cu nuclear reaction: An untapped, cost-effective and high energy production route BJB Nelson, S Leier, J Wilson, M Wuest, J Doupe, JD Andersson, F Wuest Nuclear Medicine and Biology 128, 108875, 2024 | 5 | 2024 |
| High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging B Nelson, J Wilson, J Andersson, F Wuest Nuclear Medicine and Biology 114, S12, 2022 | 3 | 2022 |
| Radiobiology of targeted alpha therapy M Schultz, JP Pouget, F Wuest, B Nelson, J Andersson, S Cheal, M Li, ... Nuclear medicine and molecular imaging 4, 380-403, 2022 | 3 | 2022 |
| Targeted alpha therapy: Progress in radionuclide production, radiochemistry, and applications. Pharmaceutics. 2021; 13: 49 BJB Nelson, JD Andersson, F Wuest s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2020 | 3 | 2020 |
| Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target B Nelson, J Wilson, J Andersson, F Wuest Nuclear Medicine and Biology 108, S171, 2022 | 2 | 2022 |
| Cyclotron target and lanthanum theranostic pair for nuclear medicine BJB Nelson, JS Wilson, JD Andersson, F Wuest US Patent App. 18/037,196, 2023 | 1 | 2023 |
| SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice N Sarrami, B Nelson, S Leier, J Wilson, C Chan, J Meens, T Komal, ... EJNMMI radiopharmacy and chemistry 9 (1), 79, 2024 | | 2024 |
| Aspects and prospects of preclinical theranostic radiopharmaceutical development BJB Nelson, V Krol, A Bansal, JD Andersson, F Wuest, MK Pandey Theranostics 14 (17), 6446, 2024 | | 2024 |
| 64Cu production via the 68Zn(p,na)64Cu nuclear reaction: Targetry, radiochemistry and PET imaging for utility assessment B Nelson, M Wuest, J Wilson, J Andersson, F Wuest NUCLEAR MEDICINE AND BIOLOGY 126, S290-S290, 2023 | | 2023 |
